Cargando…

An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer

BACKGROUND: Neoadjuvant therapy is a standard treatment for patients with large, nonmetastatic breast cancer and may allow breast-conserving surgery after tumor downsizing while decreasing the risk of subsequent relapse. Dynamic changes of circulation tumor cells (CTCs) have a role in predicting tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jinmei, Wu, Jiangling, Hao, Xiaopeng, Li, Ping, Zhang, Huiqiang, Wu, Xuexue, Chen, Jiaxin, Liu, Jiawei, Xiao, Jinyi, Zhang, Shaohua, Jiang, Zefei, Yang, Yanlian, Hu, Zhiyuan, Wang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388052/ https://www.ncbi.nlm.nih.gov/pubmed/35992876 http://dx.doi.org/10.3389/fonc.2022.966624

Ejemplares similares

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
por: Jiaxin, Chen, et al.
Publicado: (2022)

Efficacy and safety of pyrotinib and radiotherapy vs. pyrotinib-based therapy in patients with HER2(+) breast cancer with brain metastasis: a retrospective cohort study
por: Chen, Jiaxin, et al.
Publicado: (2022)

Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer
por: Zhou, Jinmei, et al.
Publicado: (2022)

Machine checkout and setup periods
por: Uythoven, J
Publicado: (2005)

Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy
por: Zhou, Ying, et al.
Publicado: (2022)

Installation, commissioning, cold checkout: summary
por: Saban, R
Publicado: (2004)

Voluntary policies on checkout foods and healthfulness of foods displayed at, or near, supermarket checkout areas: a cross-sectional survey
por: Lam, Chi Ching Vivian, et al.
Publicado: (2018)

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
por: Liu, Yi, et al.
Publicado: (2013)

Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment
por: Ji, Chenchen, et al.
Publicado: (2023)

The Potential for Healthy Checkout Policies to Advance Nutrition Equity
por: Falbe, Jennifer, et al.
Publicado: (2021)

Neighborhood sociodemographic characteristics and healthfulness of store checkouts in Northern California
por: Marinello, Samantha, et al.
Publicado: (2023)

A Framework of Visual Checkout System Using Convolutional Neural Networks for Bento Buffet
por: Wu, Mei-Yi, et al.
Publicado: (2021)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Food and Beverage Environments at Store Checkouts in California: Mostly Unhealthy Products
por: Falbe, Jennifer, et al.
Publicado: (2023)

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Paying for Express Checkout: Competition and Price Discrimination in Multi-Server Queuing Systems
por: Deck, Cary, et al.
Publicado: (2014)

Fate of Exhaled Droplets From Breathing and Coughing in Supermarket Checkouts and Passenger Cars
por: Nishandar, Sanika Ravindra, et al.
Publicado: (2023)

Device for checkout of the proportional chamber of the L3 hadron calorimeter using cosmic muons
por: Arefev, A, et al.
Publicado: (1987)

Would you like to donate your reward points today? Mental accounting and checkout charity
por: Han, Min Chung
Publicado: (2021)

The impact of a healthy checkout intervention on fruit and vegetable ‘micro-pack’ purchases in New Mexico
por: Rogus, Stephanie, et al.
Publicado: (2022)

Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study
por: Zhao, Wei, et al.
Publicado: (2020)

Can Healthy Checkout Counters Improve Food Purchases? Two Real-Life Experiments in Dutch Supermarkets
por: Huitink, Marlijn, et al.
Publicado: (2020)

Candy, Snack Food, and Soda in the Checkout Lines of Stores Selling Products for Children in New York City
por: Basch, Corey H., et al.
Publicado: (2021)

Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study
por: Li, Junjie, et al.
Publicado: (2018)

The nature of UK supermarkets’ policies on checkout food and associations with healthfulness and type of food displayed: cross-sectional study
por: Ejlerskov, Katrine T., et al.
Publicado: (2018)

Socio-economic and age variations in response to supermarket-led checkout food policies: a repeated measures analysis
por: Ejlerskov, Katrine, et al.
Publicado: (2018)

Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study
por: Yuan, Yang, et al.
Publicado: (2021)

Healthy snacks at the checkout counter: A lab and field study on the impact of shelf arrangement and assortment structure on consumer choices
por: van Kleef, Ellen, et al.
Publicado: (2012)

Supermarket policies on less-healthy food at checkouts: Natural experimental evaluation using interrupted time series analyses of purchases
por: Ejlerskov, Katrine T., et al.
Publicado: (2018)

Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study
por: Li, Feng, et al.
Publicado: (2021)

Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
por: Chantada-Vázquez, María del Pilar, et al.
Publicado: (2022)

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment
por: Wang, Mengting, et al.
Publicado: (2022)

Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
por: Wu, Jiong, et al.
Publicado: (2022)

Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
por: Oliveras-Ferraros, Cristina, et al.
Publicado: (2011)

Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer
por: Xie, Yifan, et al.
Publicado: (2021)

Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer
por: Yuan, Yang, et al.
Publicado: (2023)

Can unhealthy food purchases at checkout counters be discouraged by introducing healthier snacks? A real-life experiment in supermarkets in deprived urban areas in the Netherlands
por: Huitink, Marlijn, et al.
Publicado: (2020)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity
por: Yang, Xiao, et al.
Publicado: (2022)

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
por: Katayama, Ayaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vo98n69skkh592ji574dig3883